Bio-Data SWE — Company Map

Who actually hires a bio-data software engineer — data platforms, pipelines, lab-data infra, omics-at-scale — ranked for a Rust/systems mind that is EU-based or open to relocating
2026-07-02 · five cluster scans + the Ginkgo anchor deep-dive

A bio-data SWE builds the plumbing, not the pipettes: ELN/LIMS, workflow engines, lab-data infrastructure, omics-at-scale, ML-data infra — not wet-lab, not pure research. This page ranks the employers by fit, names the EU-friendly doors, gives the honest read on Ginkgo (the anchor you asked about), and ends with who to avoid this year.

Rust reality check

Nobody filters on Rust. The sector runs on Python / Java / TS / Go / Groovy / K8s / cloud. Verified production Rust exists only at 10x Genomics (OSS genomic libs, Go+Rust backend), the Seqera/Nextflow ecosystem (community RustQC), and narrowly at Ginkgo (gen, a git-for-DNA tool). Everywhere else Rust is a bring-it, prove-it edge you pitch for the infra / data-plane / pipeline-engine seat — not a checkbox.

Legend: EU = EU/UK-native or real EU eng hub · REM = genuine remote-EU · US = US-only (EU means relocating to the US) · [V] verified from a live source · [I] inferred.

1. Top-10 ranked shortlist

#	Company	HQ / EU hub	Flag	One-line why
1	Seqera (Nextflow/nf-core)	Barcelona, ES	EU + REM	Only shop where systems/Rust instincts touch real product — Nextflow engine + Wave/Fusion data plane; OSS flagship, $26M Series B (May 2025). [V]
2	Oxford Nanopore	Oxford / Cambridge, UK	EU	Real-time streaming nanopore data stack (Dorado basecalling, MinKNOW, EPI2ME) — low-latency rewards a systems brain; +24% rev FY25. [V]
3	BioNTech	Mainz, DE	EU (Blue Card)	The single most on-target JD: "Bioinformatics Software Engineer" — prototype→production pipelines, NextFlow/CWL/WDL, Linux, cloud; ~€17bn cash. [V]
4	AstraZeneca	Cambridge, UK	EU (Skilled Worker)	~24 comp-bio reqs; F# typed-functional research-SWE track (biologics lab-automation loop) is the closest cultural match to a Rust mind; strongest pharma momentum. [V]
5	Genomics England	London/Cambridge/Leeds, UK	EU (public body)	National-scale genomic data platform + interpretation pipelines (Nextflow, AWS, CI/CD); live Platform Engineer reqs; NHS-funded, insulated from the US layoff wave. [V]
6	DNAnexus (Prague)	Mountain View, US + Prague, CZ	EU (hybrid hub)	Live SWE + bioinformatics reqs right now in Prague on a mature big-data / agentic-omics platform (billions of rows). Pragmatic EU door into a US company. [V]
7	Cradle	Amsterdam, NL + Zurich, CH	EU (dual hub)	Purest bio-data-SWE JD in the AI cluster: "connect lab equipment ↔ data systems ↔ scientists" — LIMS-adjacent plumbing + ML-ready pipelines; $100M+, EU-native. [V]
8	10x Genomics	Pleasanton, US	US	The Rust winner — verified production Rust (OSS genomic libs, Go+Rust backend), Cell/Space/Xenium pipelines. Only if open to US relocation. [V]
9	Genedata (Danaher)	Basel, CH + Munich, DE	EU (onsite/hybrid)	Safest employer here (Danaher-owned = lowest funding risk); deep EU eng on biopharma R&D data platforms. But Java monoculture — least Rust-adjacent. [V]
10	Novartis data42	Basel, CH	EU (native)	Cleanest EU-native pharma data platform, healthy post-Sandoz, hiring senior data engineers. Caveat: Palantir Foundry shop — Foundry pipelines, not low-level systems. [V]

Just below the cut (strong, situational)

Isomorphic Labs (London — EU) — best-capitalized name anywhere ($2.1B Series B, May 2026), ~27 openings incl. London SWE; ML-data-infra + serving hot-paths. Lower only because it's drug-design-model infra, less pure lab-data. [V]
InstaDeep (London/Paris, BioNTech-owned — EU) — most stable EU AI shop after Isomorphic; 16+ roles, growing RNA/bio arm. [V]
Benchling (SF + Zurich — EU narrow) — category-leading cloud ELN+LIMS+registry; real Zurich door but narrower than the US org. [V/I]
Latent Labs (London — EU, early) — JD cites founders who "built lab data management systems"; "process complex biological data at scale." Small ($50M), pedigreed. [V]

2. Closest to Ginkgo / Ginkgo Datapoints

Ginkgo's real engineering surface = autonomous-lab scheduling/optimization, instrument drivers, and Datapoints high-throughput data pipelines (the "Bio-AI Data Provider" flywheel: automated lab → clean model-ready ADME datasets). The nearest analogues — same lab-ecosystem-data + AI-dataset shape, but with an EU story Ginkgo lacks:

Cradle (Amsterdam/Zurich) — closest overall. Literally "connect lab equipment ↔ data systems ↔ scientists" + in-house wet lab generating ML-ready data. Ginkgo's thesis, EU-native. [V]
TetraScience (Boston, ~39% US-remote) — the Tetra Scientific Data & AI Cloud: instrument connectors + data harmonization feeding AI. Purest "lab-data-platform-for-AI" peer to Datapoints. US, no EU story; 2026 Series-B extension is a momentum caution. [V/I]
Latent Labs (London) — lab-data-management heritage + "biology platform" data-at-scale infra; the EU-native, early-stage echo of the lab-in-the-loop model. [V]
Insitro (S. San Francisco) — automated wet-lab data generation ↔ ML platform, imaging pipelines, feature stores. Strong Datapoints flavor but US-only ($700M+ raised). [V]
Recursion (SLC + Oxford, UK site) — petabyte "Recursion OS" phenomics data platform + feature stores; biggest lab-data-flywheel by scale. Contracting (two ~20% cuts) — see caution list. [V]

Robot-lab / lab-OS + LIMS neighbours (data-infra, smaller/earlier): Scispot (lab OS/LIMS, remote-worldwide, relocation carrot is Canada), Latch Bio (cloud platform for biology; funding-stale), Benchling (the incumbent ELN/LIMS).

3. Best EU-friendly picks

tier A — EU-native, healthy, on-target, hiring now

Seqera (Barcelona; remote EU/UK) — best philosophical + technical fit; the data-plane/engine work is the one genuine systems-Rust surface. Watch the live board for the EU bioinformatics/SWE req to reopen.
BioNTech (Mainz) — most on-target JD, EU-native, fat cash cushion; mid-level entry (2+ yrs).
Oxford Nanopore (Oxford) — UK-native, streaming/low-latency data stack, growth momentum.
AstraZeneca (Cambridge) — biggest healthy pharma; F# track for a typed/systems mind; ~24 reqs.
Genomics England (London/Cambridge/Leeds) — Nextflow/AWS/CI-CD platform work, stable public funding.

tier B — real EU door, verify the live req

DNAnexus (Prague, hybrid) — live reqs now, mature platform.
Cradle (Amsterdam/Zurich) — purest lab-data-SWE JD, EU-native.
Genedata (Basel/Munich) — safest (Danaher), but Java-only.
Novartis data42 (Basel) — EU-native, healthy, but Foundry not systems.
Isomorphic Labs / InstaDeep (London/Paris) — best-funded / most-stable EU AI infra.
Genomics plc (Oxford) — largest human-genetics data engine, quantitative culture, plausible perf-critical hot paths; smaller/selective, watch runway.
Benchling (Zurich) / Latent Labs / Bioptimus (Paris) — narrower or earlier; confirm reqs.
Lifebit (London/Lisbon, "Anywhere in Europe") — genuinely remote-EU, but thin hiring + stale 2021 Series B; verify momentum first.

Visa note: UK (AstraZeneca, ONT, Genomics England/plc, Isomorphic), DE (BioNTech Blue Card, InstaDeep-Berlin), ES (Seqera), NL/CH (Cradle), DK/CZ all have routine sponsorship paths. Switzerland is non-EU (Basel/Zurich = work permit, not freedom-of-movement). Confirm sponsorship per-req — few postings publish it.

4. The Ginkgo read — honest

THE STORY

2026 pivot to Autonomous Labs + Ginkgo Datapoints (selling AI-training biological datasets; the ADME-One platform with Tangible Scientific + Inductive Bio). Real, interesting scheduling / instrument-driver / high-throughput-pipeline systems work.

THE WALLS

Revenue −49% YoY (Q1'26), deeply loss-making, post-1:40 reverse split, ~35% headcount cut. ~15 roles, all Boston/US, no EU presence, no visa language. Stack is Ruby/Python/JS (Rust only in the tiny gen tool).

Verdict: a turnaround bet, not a destination. For an EU-based Rust/systems engineer the geographic + stack + company-risk walls are decisive — pass, unless you would relocate to Boston and want in on the Datapoints flywheel. The five analogues in §2 give you the same lab-ecosystem-data shape with an EU door. [V]

5. Avoid / caution (honest)

Actively contracting — wrong year to walk in

Novo Nordisk (Bagsværd) — EU-native but ~9,000 jobs cut (11%, 5k in DK); deprioritize. [V]
Recursion (SLC/Oxford) — two ~20% cuts, runway-driven consolidation. [V]
Illumina — ~12% cut over the trailing year, Grail impairment, margin mode. Aim only if a specific Cambridge-UK DRAGEN req fits. [V]
Roche/Genentech — good data-org thesis but US gRED in multi-round restructuring (~350+ R&D cuts). Aim Basel/pRED, avoid SSF. [V]

Funding-stale / small — verify runway first

Latch Bio (SF) — no fresh round since Series A (Jun 2022). [V]
Form Bio (Dallas) — ~35 employees, $30M Series A (2022), no round since — highest risk. [V]
Lifebit (London/Lisbon) — 5-year-old Series B, thin current board. [I]
Color (Burlingame) — more product than omics-data, mid-pivot, stale 2021 valuation. [V/I]

US-only (no EU relocation story)

Tempus, Guardant, Freenome, Nucleus, TetraScience, Flywheel, Insitro, Chai Discovery, EvolutionaryScale (also mid-restructure inside CZI/Biohub), Element, Ultima, PacBio, 10x (the Rust exception — worth US relocation only if Rust is the priority). Merck: US-centric and selective visa and 2028 Keytruda cliff.

Culture mismatch for a systems/Rust person (good companies, wrong shape)

Novartis data42 — Palantir Foundry drag-and-drop, not systems.
Genedata — Java monoculture.
GSK.ai — ML-engineering + PhD-preference culture.
Element Biosciences — TS/React/Electron web-heavy.

The move: Seqera or BioNTech for the on-target seat, DNAnexus-Prague for the doorstep EU door, Oxford Nanopore / Genomics England for the low-latency data-platform work. Ginkgo is a turnaround you skip — its EU-native analogues (Cradle, Latent Labs) give you the same lab-data flywheel without the walls. Rust is the edge you bring, not the filter they run.